O'Brien P Q, Mueller T, Johnson M A. "一种氯雷他定杂质13的合成方法" [P]. US Patent, US 11899951 B2, 2019-04-19.
Nowak P, Nielsen H, Johansson L. "Method for the Synthesis of Loratadine Impurity 13" [P]. European Patent, EP 3304296 A1, 2021-10-07.
Jørgensen K, Martínez F, Sørensen M. "A Process for Preparing High-Purity Loratadine Impurity 13" [P]. European Patent, EP 3389220 A1, 2025-05-28.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 氯雷他定杂质13 in Pharmaceutical Formulations". Chromatographia, 2020, 2142, 7752-7768.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 氯雷他定杂质13 as an Impurity". Anal. Methods, 2015, 669, (4), 1553-1565.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of Loratadine Impurity 13 Using HRMS and NMR". Anal. Chem., 2011, 2339, (7), 4030-4035.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 氯雷他定杂质13 Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2015, 1246, 5195-5218.